PMID: 8968303Nov 1, 1996Paper

Development of major depressive disorder during smoking-cessation treatment

The Journal of Clinical Psychiatry
Belinda BorrelliDavid B Abrams

Abstract

Several studies have shown an association between smoking and major depressive disorder (MDD), but few have prospectively examined subjects who develop MDD after quitting smoking. This descriptive study evaluated the development of MDD after smoking cessation, as assessed by a structured clinical interview at both baseline and the end of treatment. Nondepressed participants (N = 114) in a trial investigating the effect of fluoxetine on smoking cessation were administered the Structured Clinical Interview for DSM-III-R at baseline and posttreatment to evaluate the impact of quitting smoking on the development of MDD. Depressive symptoms were additionally assessed with the Beck Depression Inventory and the Hamilton Rating Scale for Depression. At baseline, 32% of the subjects reported a history of MDD. Sixty-nine subjects completed the SCID at baseline and posttreatment. At posttreatment, 5 subjects (7%) met threshold criteria for MDD; none were taking the highest dose of fluoxetine (60 mg), 4 were taking 30 mg, and 1 was taking placebo. All 5 had a history of MDD; 3 were women. Four had a history of substance abuse and attained at least 3 consecutive biochemically verified weeks of smoking abstinence. Those who developed MDD aft...Continue Reading

Citations

Jan 17, 2004·Psychopharmacology·Jessica Werth CookJean Kristeller
Jan 12, 2008·Journal of Human Genetics·Colin O'GaraIan Craig
Nov 15, 2001·Current Psychiatry Reports·R P LajeA H Glassman
Aug 17, 2012·Neurotoxicity Research·Laura L Hurley, Yousef Tizabi
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·P J Kenny, A Markou
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·S LeonardR Freedman
Mar 12, 2003·Addictive Behaviors·Joel D KillenAnn Varady
Mar 9, 2000·Addictive Behaviors·C D Williams, L L Adams-Campbell
Jan 11, 2000·Addictive Behaviors·B BorrelliM Roberts
Mar 21, 2003·Journal of Substance Abuse Treatment·Ovide F PomerleauKaren K Saules
Apr 18, 2003·Journal of Consulting and Clinical Psychology·Paul M CinciripiniWalter F Baile
Aug 20, 2003·Journal of Consulting and Clinical Psychology·Brian HitsmanRaymond Niaura
Dec 22, 2005·Experimental and Clinical Psychopharmacology·Paul M CinciripiniJohn D Minna
Sep 23, 2009·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Lisa M Fucito, Laura M Juliano
Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Uma RaoRussell E Poland
Oct 23, 1997·The New England Journal of Medicine·N L Benowitz
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·R NiauraM G Goldstein
Mar 31, 2009·Annual Review of Clinical Psychology·Sharon M Hall, Judith J Prochaska
Jan 5, 2002·Pharmacotherapy·M KotlyarB D Jamerson
May 7, 2013·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Jennifer A MinnixPaul M Cinciripini
Jul 24, 2014·Psychological Medicine·P A Cavazos-RehgL J Bierut
Mar 3, 2012·Current Cardiovascular Risk Reports·Andrew M BuschAdam M Leventhal
Feb 6, 2009·Current Medical Research and Opinion·Henri-Jean Aubin
Sep 12, 2015·The American Journal on Addictions·Marya MorozovaTony P George
Feb 17, 2009·Addictive Behaviors·Annette K McClaveAli H Mokdad
Jan 27, 2009·Addictive Behaviors·Les B WhitbeckDevan M Crawford
Apr 17, 2008·Addiction·Sharon S AllenDorothy Hatsukami
Jun 26, 2013·Journal of Research on Adolescence : the Official Journal of the Society for Research on Adolescence·Les B WhitbeckDevan M Crawford
Sep 29, 2004·Addictive Behaviors·Joel D KillenAlan F Schatzberg
Feb 14, 2007·Journal of Consulting and Clinical Psychology·Bonnie SpringDonald Hedeker
Mar 13, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Alexa A LopezStephen T Higgins
Jul 15, 2003·Human Psychopharmacology·Elizabeth J Corwin, Laura Cousino Klein
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Amanda C FarleyPaul Aveyard
Jan 10, 2014·The Cochrane Database of Systematic Reviews·John R HughesTim Lancaster
Apr 3, 2007·Obstetrics and Gynecology·Renee D GoodwinNicole Simuro
Jun 15, 2005·Psychosomatic Medicine·Kenneth E FreedlandJudith A Skala
Feb 24, 2006·Drug and Alcohol Review·Kay WilhelmFrances Kay-Lambkin
Oct 16, 2002·Oncogene·Caryn Lerman, Raymond Niaura
Apr 23, 2020·The Cochrane Database of Systematic Reviews·Seth HowesNicola Lindson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.